Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy
Ying Hao, Yuwen Chen, Xinlong He, et al.
Biomaterials (2022) Vol. 293, pp. 121975-121975
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
Jingyuan Dai, Milad Ashrafizadeh, Amir R. Aref, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103981-103981
Closed Access | Times Cited: 65
Designing nanozymes for in vivo applications
Ruofei Zhang, Bing Jiang, Kelong Fan, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 10, pp. 849-868
Closed Access | Times Cited: 63
Cuproptosis‐Driven Enhancement of Thermotherapy by Sequentially Response Cu2‐xSe via Copper Chemical Transition
Leung Chan, Yongkang Liu, Muhe Chen, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 33
Closed Access | Times Cited: 44
Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
Shuxin Yan, Jintong Na, Xiyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 248-248
Open Access | Times Cited: 39
Biointerface‐Engineered Hybrid Nanovesicles for Targeted Reprogramming of Tumor Microenvironment
Xueyan Zhen, Yongjiang Li, Wanqing Yuan, et al.
Advanced Materials (2024) Vol. 36, Iss. 41
Closed Access | Times Cited: 23
Rational Design of Nanozymes for Engineered Cascade Catalytic Cancer Therapy
Xiuna Jia, Erkang Wang, Jin Wang
Chemical Reviews (2025)
Closed Access | Times Cited: 3
Targeted delivery of PROTAC-based prodrug activated by bond-cleavage bioorthogonal chemistry for microneedle-assisted cancer therapy
Jing Huang, Zhuo Yao, Bowen Li, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 270-279
Closed Access | Times Cited: 27
Peptide nanozymes: An emerging direction for functional enzyme mimics
Shao‐Bin He, Long Ma, Qionghua Zheng, et al.
Bioactive Materials (2024) Vol. 42, pp. 284-298
Closed Access | Times Cited: 12
Hyaluronan-decorated copper-doxorubicin-anlotinib nanoconjugate for targeted synergistic chemo/chemodynamic/antiangiogenic tritherapy against hepatocellular carcinoma
Gang Tan, Guanghui Hou, Junmin Qian, et al.
Journal of Colloid and Interface Science (2024) Vol. 662, pp. 857-869
Closed Access | Times Cited: 9
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment
Soniya Kumbham, Kazi Md Mahabubur Rahman, Barbara A. Foster, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 2, pp. 286-307
Closed Access | Times Cited: 1
Nanozyme-Based Remodeling of Disease Microenvironments for Disease Prevention and Treatment: A Review
Yikun Ju, Xiangjun Liu, Xiuzhi Ye, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 15, pp. 13792-13823
Closed Access | Times Cited: 17
Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy
Chan Ho Kim, Kyu Eun Lee, Hyewon Ko, et al.
Chemistry of Materials (2024) Vol. 36, Iss. 3, pp. 1088-1112
Closed Access | Times Cited: 8
Zeolitic imidazole framework-derived rich-Zn-Co3O4/N-doped porous carbon with multiple enzyme-like activities for synergistic cancer therapy
Yulin Zhong, Xu Zhang, Ai‐Jun Wang, et al.
Journal of Colloid and Interface Science (2024) Vol. 665, pp. 1065-1078
Closed Access | Times Cited: 8
Ferrous Selenide Stabilized Black Phosphorus Heterojunction Sonosensitizer for MR Imaging-Guided Sonodynamic Therapy of Bladder Cancer
Sicheng Wu, Guanlin Li, Wenrui Ouyang, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 6
Utilization of aggregation‐induced emission materials in urinary system diseases
Haodong Xu, Xin Chen, He Wang, et al.
Aggregate (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 6
Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review
Xing Yang, Feroza Yasinjan, Shuhao Sun, et al.
Nano Today (2024) Vol. 57, pp. 102386-102386
Closed Access | Times Cited: 6
Bacteria and Bacterial Components as Natural Bio-Nanocarriers for Drug and Gene Delivery Systems in Cancer Therapy
Rui Zong, Hainan Ruan, Chan‐Min Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2490-2490
Open Access | Times Cited: 16
Hydrogel design to overcome thermal resistance and ROS detoxification in photothermal and photodynamic therapy of cancer
Da In Jeong, Hyun Jin Kim, Song Yi Lee, et al.
Journal of Controlled Release (2023) Vol. 366, pp. 142-159
Closed Access | Times Cited: 11
Nanomedicine alleviates doxorubicin-induced cardiotoxicity and enhances chemotherapy synergistic chemodynamic therapy
Yaqian He, Xiaoying Liu, Zichuang Xu, et al.
Journal of Colloid and Interface Science (2024) Vol. 663, pp. 1064-1073
Closed Access | Times Cited: 4
NIR-II light powered hydrogel nanomotor for intravesical instillation with enhanced bladder cancer therapy
Wei Chen, Yingfei Wang, Hao Hu, et al.
Nanoscale (2024) Vol. 16, Iss. 21, pp. 10273-10282
Closed Access | Times Cited: 4
Glutathione-depleting polyprodrug nanoparticle for enhanced photodynamic therapy and cascaded locoregional chemotherapy
Xinlu Zhang, Xu Zhang, Shutong Chen, et al.
Journal of Colloid and Interface Science (2024) Vol. 670, pp. 279-287
Closed Access | Times Cited: 4
Peptide Nanomaterials for Cancer Therapy
Yi Cao, Pin Wang, Xiaojiao Ge, et al.
(2025), pp. 101-131
Closed Access
Copper-based hollow mesoporous nanogenerator with reactive oxygen species and reactive nitrogen species storm generation for self-augmented immunogenic cell death-mediated triple-negative breast cancer immunotherapy
Quan Jing, Jinlong Zhang, L. Yuan, et al.
Journal of Colloid and Interface Science (2025) Vol. 688, pp. 688-702
Closed Access
Self-assembled nanoplatform-mediated co-delivery of brusatol to sensitize sorafenib for hepatocellular carcinoma treatment
Fengrui Liu, Senlin Li, Chengcheng Huang, et al.
RSC Advances (2025) Vol. 15, Iss. 15, pp. 11675-11687
Open Access
Peptide-photosensitizer conjugates: From molecular design to function and antibacterial applications
Guanghui Zhao, Peng Tan, Qi Tang, et al.
Chemical Engineering Journal (2025), pp. 162723-162723
Closed Access
Page 1 - Next Page

Scroll to top